logo-loader
viewCello Health PLC

Cello Health trumpets first half performance

Improvements in net revenues, pre-tax profit, earnings per share and margins all contributed to a strong opening six months for the advisory group

woman surgeon
The company provides business insights, analytics and marketing services to the healthcare sector

Cello Health PLC (LON:CLL) said it expects 2019 results to be “at least in line with current expectations” as it registered growth right across the business.

Improvements in net revenues, pre-tax profit, earnings per share and margins all contributed to a strong opening six months for the advisory group.

Its health division expanded organically both in Europe and the US.

Berlin and Boston buoyant

“The office in Berlin is now fully operational and project work is starting to be serviced from there,” investors were told in a trading update.

“The level of investment in the Boston area has also increased as a result of significant new clients wins in the region.”

Cello Signal, the company’s marketing agency, had a solid start to the year, “with a performance similar to that in the first half of 2018”. It should be noted Signal’s profits tend to be second-half weighted.

In the update, Cello said its balance sheet was strong, resulting in a net cash position at the end of June. The introduction of new accounting rules, called IFRS 16, would have minimal impact on profits, it added.

Quick facts: Cello Health PLC

Price: 128.5 GBX

AIM:CLL
Market: AIM
Market Cap: £136.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19

RNS

Total Voting Rights

1 week, 3 days ago

Holding(s) in Company

3 weeks ago

Holding(s) in Company

4 weeks, 1 day ago

Total Voting Rights

1 month ago

Total Voting Rights

on 7/10/19

Disposal

on 2/10/19

Interim Results

on 18/9/19

2 min read